HeartWare employs approximately 137 personnel.  Set out below are brief biographies of the Company's senior executives.

Douglas Godshall
Managing Director, Chief Executive Officer

Doug joined HeartWare as Chief Executive Officer in September 2006.  An experienced medical device executive, Doug has overall responsibility for developing and executing HeartWare's strategic plan and for delivering key corporate, operational and financial objectives.

Prior to joining HeartWare, Doug spent over 16 years at Boston Scientific, most recently as President of the Vascular Surgery Division.  He previously spent five years as Vice President, Business Development where he was instrumental in developing the acquisition strategies for the cardiology, electrophysiology, neuroradiology and vascular surgery divisions.  He led the negotiation and structuring of over 70 transactions and represented Boston Scientific on the Boards of 11 companies.  Prior to assuming the Business Development position, he was Director of Marketing for Boston Scientific's Urology Division, where he helped to build global sales to over US$150 million.

Doug has established and led executive teams through the clinical development, market launch and commercial rollout of a range of medical devices.  He has a track record of identifying and successfully executing substantial business partnerships and brings to HeartWare a breadth of financial, strategic and operational relationships.

David McIntyre
EVP, Chief Financial Officer and Chief Operating Officer

David joined HeartWare shortly after the IPO.  He is an experienced medical device industry executive with both development-stage and large corporate credentials. David has directed the Company's strategic financial plan, including raising capital and listing on Nasdaq.  He also serves as operational leader of HeartWare's Miami Lakes Technology Center.

Prior to joining HeartWare, David was the Chief Financial Officer and General Counsel to another ASX-listed medical device company.  He has previously served as a corporate and commercial law specialist in major international law firms, advising some of the world's largest corporations in various areas including mergers and acquisitions, corporate fundraising and securities law.  He has also held senior financial roles in multinational companies, among them Rio Tinto.

David holds a Bachelor of Economics, majoring in accounting from the University of Sydney and a Bachelor of Laws from the University of Technology, Sydney.  He is admitted as a Solicitor of the Supreme Court of New South Wales and is a member of the Law Society of New South Wales and CPA Australia.

Jeffrey A. LaRose
EVP, Chief Scientific Officer

Jeff has been the driving force behind the development of HeartWare's technologies for the past eight years.  He is responsible for all aspects of the design of the HeartWare HVAD^TM System and he leads the development of HeartWare's device miniaturisation program.  

Jeff has over 20 years experience in hydraulic technology development including roles with AEA Technology Engineering Software and Babcock and Wilcox.  He holds a Master of Science in Mechanical Engineering.

Dr David Hathaway
Chief Medical Officer

David is responsible for all medical and clinical affairs, including the design and execution of HeartWare's clinical trial program.  

David was previously Vice President of Medical Affairs with Knoll Pharmaceutical Company until it was acquired by Abbott Laboratories. He oversaw the Medical Affairs Department and was responsible for clinical research, regulatory affairs, medical information and drug advocacy. Prior to joining Knoll, David was Vice President, Cardiovascular Drug Discovery at Bristol-Myers Squibb, where he managed a team of 90 scientists. Before transitioning to a corporate career, he was Division Chief and Director of the Krannert Institute of Cardiology at the Indiana University School of Medicine, where he practiced for more than 14 years. He also served as a Clinical Associate and Cardiology Fellow at the National Institutes of Health in Bethesda, Md.

David has been section editor (Cardiovascular Diseases) of Kelley's Textbook of Medicine and a member of the editorial boards of the Journal of Clinical Investigation, the Journal of the American College of Cardiology and Circulation. He has authored over 80 scientific and medical publications and is an inventor on 13 U.S. patents and 8 pending U.S. patent applications. He is a member of the Association of American Physicians, the American College of Physicians and the American Society for Clinical Investigation and is a fellow in the American College of Cardiology.  He earned his medical degree from the Indiana University School of Medicine.

James Schuermann
Vice President, Sales and Marketing

Jim joined HeartWare in September 2007.  He has overall responsibility for HeartWare's sales and marketing activities across all markets.    

Jim has over 16 years sales and marketing experience in the medical device arena. Prior to joining HeartWare, he spent nine years in sales and marketing at Boston Scientific Corporation.  Over this time he progressed from field sales through product management until being appointed Director of Marketing for the Urology & Gynecology Division at the company's corporate headquarters in Natick, MA. In this role Jim led the marketing and product management activities for a $280M worldwide business.  Before joining Boston Scientific, he spent five years in medical sales and sales management in the Patient Care Division for Sherwood Davis & Geck (now a Covidien company).  Jim began his business career as a Marketing Representative for Armstrong World Industries, Inc.  Jim received a Bachelor of Science in Marketing from the Kelley School of Business, Indiana University, Bloomington, and his Master in Business Administration from the Ageno School of Business, Golden Gate University, San Francisco.

Ramon Augusto Paz
Vice President, Quality Assurance

Ramon joined HeartWare as Director of Quality Assurance in October 2004.  He has primary responsibility for establishing and managing the company's Quality Management System.

Ramon has over 23 years of multifunctional experience in the medical device industry across Quality, Manufacturing, Engineering, Regulatory and Clinical organizations.  He began his career with Cordis Corporation, where he spent 15 years in a range of progressively more senior positions across the Quality, Manufacturing and Product Development groups.  In 1998 Ramon joined World Medical, a start-up company which was later acquired by MedtronicAVE, where Ramon was Head of Quality, with expanded responsibility for managing the regulatory and clinical groups responsible for the clinical study of the TALENT stent graft.